• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离体神经末梢中调节突触前释放的 NMDA 受体:叙事性综述。

Presynaptic release-regulating NMDA receptors in isolated nerve terminals: A narrative review.

机构信息

Department of Pharmacology (DIFAR), School of Medical and Pharmaceutical Sciences, 3Rs Center, University of Genova, Italy.

San Martino Hospital IRCCS, Genova, Italy.

出版信息

Br J Pharmacol. 2021 Mar;178(5):1001-1017. doi: 10.1111/bph.15349. Epub 2021 Feb 2.

DOI:10.1111/bph.15349
PMID:33347605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9328659/
Abstract

The existence of presynaptic, release-regulating NMDA receptors in the CNS has been long matter of discussion. Most of the reviews dedicated to support this conclusion have preferentially focussed on the results from electrophysiological studies, paying little or no attention to the data obtained with purified synaptosomes, even though this experimental approach has been recognized as providing reliable information concerning the presence and the role of presynaptic release-regulating receptors in the CNS. To fill the gap, this review is dedicated to summarising the results from studies with synaptosomes published during the last 40 years, which support the existence of auto and hetero NMDA receptors controlling the release of transmitters such as glutamate, GABA, dopamine, noradrenaline, 5-HT, acetylcholine and peptides, in the CNS of mammals. The review also deals with the results from immunochemical studies in isolated nerve endings that confirm the functional observations.

摘要

中枢神经系统中存在突触前、释放调节型 NMDA 受体,这一直是讨论的主题。大多数支持这一结论的综述文章都优先关注电生理学研究的结果,而很少或根本不关注用纯化的突触小体获得的数据,尽管这种实验方法已被认为能提供有关中枢神经系统中存在突触前释放调节受体及其作用的可靠信息。为了填补这一空白,本综述专门总结了过去 40 年来用突触小体进行的研究结果,这些研究支持了自动和异 NMDA 受体的存在,这些受体控制着诸如谷氨酸、GABA、多巴胺、去甲肾上腺素、5-HT、乙酰胆碱和肽等递质在哺乳动物中枢神经系统中的释放。该综述还涉及到在分离的神经末梢进行的免疫化学研究的结果,这些结果证实了功能观察。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2944/9328659/552855553a35/BPH-178-1001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2944/9328659/80d8773ef894/BPH-178-1001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2944/9328659/552855553a35/BPH-178-1001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2944/9328659/80d8773ef894/BPH-178-1001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2944/9328659/552855553a35/BPH-178-1001-g001.jpg

相似文献

1
Presynaptic release-regulating NMDA receptors in isolated nerve terminals: A narrative review.离体神经末梢中调节突触前释放的 NMDA 受体:叙事性综述。
Br J Pharmacol. 2021 Mar;178(5):1001-1017. doi: 10.1111/bph.15349. Epub 2021 Feb 2.
2
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals.在大鼠和人类去甲肾上腺素能神经末梢上共同表达的突触前N-甲基-D-天冬氨酸受体与代谢型谷氨酸受体之间的功能相互作用。
Br J Pharmacol. 2007 Aug;151(7):1087-94. doi: 10.1038/sj.bjp.0707280. Epub 2007 Jun 25.
3
Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.含 GluN3A 的 NMDA 型自身受体的免疫药理学特征:与抗 NMDA 受体自身免疫性疾病的相关性。
Mol Neurobiol. 2019 Sep;56(9):6142-6155. doi: 10.1007/s12035-019-1511-8. Epub 2019 Feb 7.
4
Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals.突触前谷氨酸受体调节离体神经末梢去甲肾上腺素的释放。
J Neurochem. 1992 Jan;58(1):204-11. doi: 10.1111/j.1471-4159.1992.tb09297.x.
5
Presynaptic glutamate receptors modulate dopamine release from striatal synaptosomes.突触前谷氨酸受体调节纹状体突触小体释放多巴胺。
J Neurochem. 1991 Sep;57(3):819-22. doi: 10.1111/j.1471-4159.1991.tb08224.x.
6
Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.调节去甲肾上腺素释放的人脑海马N-甲基-D-天冬氨酸受体受到HIV-1外壳蛋白gp120的正向调节。
AIDS. 1996 May;10(5):463-8. doi: 10.1097/00002030-199605000-00003.
7
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings.生长抑素诱导的N-甲基-D-天冬氨酸受体功能激活及上调:通过海马去甲肾上腺素能神经末梢中的钙调蛋白依赖性蛋白激酶II、磷脂酶C、蛋白激酶C和酪氨酸激酶介导
J Pharmacol Exp Ther. 2005 Apr;313(1):242-9. doi: 10.1124/jpet.104.079590. Epub 2004 Dec 17.
8
Prolonged nicotine exposure down-regulates presynaptic NMDA receptors in dopaminergic terminals of the rat nucleus accumbens.长期暴露于尼古丁会下调大鼠伏隔核多巴胺能终末的突触前NMDA受体。
Neuropharmacology. 2014 Apr;79:488-97. doi: 10.1016/j.neuropharm.2013.12.014. Epub 2013 Dec 25.
9
Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.大鼠纹状体中谷氨酸能对多巴胺释放的控制:多巴胺能神经末梢上突触前N-甲基-D-天冬氨酸受体的证据。
J Neurochem. 1991 Jan;56(1):81-5. doi: 10.1111/j.1471-4159.1991.tb02565.x.
10
Pharmacological heterogeneity of release-regulating presynaptic AMPA/kainate receptors in the rat brain: study with receptor antagonists.大鼠脑中释放调节性突触前AMPA/海人酸受体的药理学异质性:用受体拮抗剂进行的研究
Neurochem Int. 2003 Mar;42(4):283-92. doi: 10.1016/s0197-0186(02)00129-8.

引用本文的文献

1
Randomized Placebo-Controlled Trial of Memantine for Smoking Cessation (CCCWFU 99311).美金刚用于戒烟的随机安慰剂对照试验(CCCWFU 99311)
Cancer Control. 2025 Jan-Dec;32:10732748251336416. doi: 10.1177/10732748251336416. Epub 2025 May 8.
2
Non-canonical Roles of Complement in the CNS: From Synaptic Organizer to Presynaptic Modulator of Glutamate Transmission.补体在中枢神经系统中的非经典作用:从突触组织者到谷氨酸传递的突触前调节剂。
Curr Neuropharmacol. 2025;23(7):820-834. doi: 10.2174/011570159X327960240823065729.
3
Pharmacological target sites for restoration of age-associated deficits in NMDA receptor-mediated norepinephrine release in brain.

本文引用的文献

1
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update.突触前释放调节型代谢型谷氨酸受体:最新进展。
Curr Neuropharmacol. 2020;18(7):655-672. doi: 10.2174/1570159X17666191127112339.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors.2019/20 年药理学简明指南:G 蛋白偶联受体。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S21-S141. doi: 10.1111/bph.14748.
3
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels.《药理学 2019/20 简明指南:离子通道》
恢复大脑中NMDA受体介导的去甲肾上腺素释放与年龄相关缺陷的药理学靶点
J Neurochem. 2025 Jan;169(1):e16280. doi: 10.1111/jnc.16280.
4
Estrogen Receptor Beta Agonist Influences Presynaptic NMDA Receptor Distribution in the Paraventricular Hypothalamic Nucleus Following Hypertension in a Mouse Model of Perimenopause.在围绝经期小鼠高血压模型中,雌激素受体β激动剂对下丘脑室旁核突触前N-甲基-D-天冬氨酸受体分布的影响
Biology (Basel). 2024 Oct 12;13(10):819. doi: 10.3390/biology13100819.
5
Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine-Glutamate Crosstalk.涉及甘氨酸和其他氨基酸神经递质的相互作用:聚焦于转运体介导的释放调节及甘氨酸-谷氨酸相互作用
Biomedicines. 2024 Jul 8;12(7):1518. doi: 10.3390/biomedicines12071518.
6
Interactions between Glycine and Glutamate through Activation of Their Transporters in Hippocampal Nerve Terminals.甘氨酸与谷氨酸在海马神经终末通过激活其转运体发生的相互作用。
Biomedicines. 2023 Nov 27;11(12):3152. doi: 10.3390/biomedicines11123152.
7
Molecular Mechanisms of the Regulation of Liver Cytochrome P450 by Brain NMDA Receptors and via the Neuroendocrine Pathway-A Significance for New Psychotropic Therapies.脑 NMDA 受体调控肝细胞色素 P450 的分子机制及其通过神经内分泌途径的作用——对新型精神药物治疗的意义。
Int J Mol Sci. 2023 Nov 28;24(23):16840. doi: 10.3390/ijms242316840.
8
Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic.中枢神经系统疾病中的抗 NMDA 和抗 AMPA 受体抗体:评估其病理性作用及向临床转化的转化医学研究方法。
Int J Mol Sci. 2023 Oct 5;24(19):14905. doi: 10.3390/ijms241914905.
9
Involvement of P2Y, P2Y, A and A Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex.P2Y、P2Y1、A 和 A 受体参与嘌呤能抑制大鼠大脑皮质 NMDA 诱发的去甲肾上腺素释放。
Cells. 2023 Jun 22;12(13):1690. doi: 10.3390/cells12131690.
10
Attenuation of Stimulated Accumbal Dopamine Release by NMDA Is Mediated through Metabotropic Glutamate Receptors.NMDA对伏隔核刺激诱导的多巴胺释放的抑制作用是通过代谢型谷氨酸受体介导的。
ACS Chem Neurosci. 2023 Apr 6;14(8):1449-58. doi: 10.1021/acschemneuro.2c00777.
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S142-S228. doi: 10.1111/bph.14749.
4
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes.2019/20 年简明药理学指南:酶。
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S297-S396. doi: 10.1111/bph.14752.
5
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters.《药理学概要 2019/20:转运蛋白》
Br J Pharmacol. 2019 Dec;176 Suppl 1(Suppl 1):S397-S493. doi: 10.1111/bph.14753.
6
Acute Functional Adaptations in Isolated Presynaptic Terminals Unveil Synaptosomal Learning and Memory.孤立突触前末梢的急性功能适应揭示了突触小体的学习和记忆。
Int J Mol Sci. 2019 Jul 25;20(15):3641. doi: 10.3390/ijms20153641.
7
The selective disruption of presynaptic JNK2/STX1a interaction reduces NMDA receptor-dependent glutamate release.选择性破坏突触前 JNK2/STX1a 相互作用可减少 NMDA 受体依赖性谷氨酸释放。
Sci Rep. 2019 May 9;9(1):7146. doi: 10.1038/s41598-019-43709-2.
8
Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.含 GluN3A 的 NMDA 型自身受体的免疫药理学特征:与抗 NMDA 受体自身免疫性疾病的相关性。
Mol Neurobiol. 2019 Sep;56(9):6142-6155. doi: 10.1007/s12035-019-1511-8. Epub 2019 Feb 7.
9
Triheteromeric NMDA receptors: from structure to synaptic physiology.三聚体 N-甲基-D-天冬氨酸受体:从结构到突触生理学
Curr Opin Physiol. 2018 Apr;2:1-12. doi: 10.1016/j.cophys.2017.12.004. Epub 2017 Dec 19.
10
Towards resolving the presynaptic NMDA receptor debate.为了解决 NMDA 受体突触前争论。
Curr Opin Neurobiol. 2018 Aug;51:1-7. doi: 10.1016/j.conb.2017.12.020. Epub 2018 Jan 30.